These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 4956802)

  • 21. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
    Li J; Munsiff SS; Driver CR; Sackoff J
    Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New derivatives of rifamycin antibiotics.
    Bickel H; Knüsel F; Kump W; Neipp L
    Antimicrob Agents Chemother (Bethesda); 1966; 6():352-8. PubMed ID: 5985257
    [No Abstract]   [Full Text] [Related]  

  • 23. [Physio-chemical considerations on a chromatic phenomenon produced by a mixture of rifamycin S and SV in the free acid state].
    Curci G; Sarluca F
    G Ital Chemioter; 1966; 13(1):27-31. PubMed ID: 5994447
    [No Abstract]   [Full Text] [Related]  

  • 24. Can studies of the early bactericidal activity of rifapentine tell us how to prevent acquired rifamycin-resistant relapse?
    Wallis RS
    Am J Respir Crit Care Med; 2005 Jul; 172(1):4-5. PubMed ID: 15980108
    [No Abstract]   [Full Text] [Related]  

  • 25. [Studies on pyrazine derivatives. XIX. Synthesis and tuberculostatic activity of various 3-phenoxy-2-pyrazinecarboxylic acid derivatives].
    Pancechowska-Ksepko D; Foks H; Janowiec M
    Acta Pol Pharm; 1983; 40(1):15-9. PubMed ID: 6410689
    [No Abstract]   [Full Text] [Related]  

  • 26. Structure-activity relationships of rifamycin derivatives.
    Sensi P
    Acta Tuberc Pneumol Belg; 1969; 60(3):258-65. PubMed ID: 5371662
    [No Abstract]   [Full Text] [Related]  

  • 27. [Bacteriostatic effect of rifampicin (Rifampin) on Mycobacterium tuberculosis in vitro].
    Woźniak S; Tomaszkiewicz L; Zierski M
    Gruzlica; 1969 Nov; 37(11):983-9. PubMed ID: 4983868
    [No Abstract]   [Full Text] [Related]  

  • 28. Rifamycins. XLI. A new class of active semisynthetic rifamycins. N-substituted aminomethyl derivatives of rifamycin SV 2.
    Maggi N; Arioli V; Sensi P
    J Med Chem; 1965 Nov; 8(6):790-3. PubMed ID: 5885073
    [No Abstract]   [Full Text] [Related]  

  • 29. [Synthesis and tuberculostatic action of various 1-H-imidazo(4,5-c)pyridine derivatives].
    Czarnocka-Janowicz A; Janowiec M
    Acta Pol Pharm; 1983; 40(1):7-14. PubMed ID: 6410691
    [No Abstract]   [Full Text] [Related]  

  • 30. [Susceptibility test to rifampin by using quantitative analysis of Mycobacterium tuberculosis mRNA].
    Lu Y; Zhu LZ; Chu NH; Duan LS; Liang GF
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Aug; 27(8):549-52. PubMed ID: 15388006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Synthesis of derivatives of N-hydroxyalkylimidazolidine-2-thione].
    Wisterowicz K; Sawlewicz J; Wilińska B
    Acta Pol Pharm; 1983; 40(2):139-45. PubMed ID: 6419548
    [No Abstract]   [Full Text] [Related]  

  • 32. [Rapid detection of Mycobacterium tuberculosis resistance to rifampin using DNA chip].
    Jing F; Hu Z; Sun Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Sep; 24(9):551-4. PubMed ID: 11758172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Synthesis and tuberculostatic activity of various 2-mercapto- and 2-oxoimidazo (4,5-c)pyridine derivatives].
    Czarnocka-Janowicz A; Janowiec M; Stambrowska A
    Acta Pol Pharm; 1983; 40(1):21-31. PubMed ID: 6410690
    [No Abstract]   [Full Text] [Related]  

  • 34. [Resistance to rifampin of mycobacterium tuberculosis and rpoB gene].
    Huang H; Ma Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Nov; 23(11):692-4. PubMed ID: 11225038
    [No Abstract]   [Full Text] [Related]  

  • 35. Multiplex detection of mutations in clinical isolates of rifampin-resistant Mycobacterium tuberculosis by short oligonucleotide ligation assay on DNA chips.
    Deng JY; Zhang XE; Lu HB; Liu Q; Zhang ZP; Zhou YF; Xie WH; Fu ZJ
    J Clin Microbiol; 2004 Oct; 42(10):4850-2. PubMed ID: 15472360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study of the pathogenicity, in the guinea-pig, of strains of mycobacterium tuberculosis resistant to rifampicin].
    Timoşca S; Petreanu V; Labă E; Georgescu M; Martinescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):309-14. PubMed ID: 6304844
    [No Abstract]   [Full Text] [Related]  

  • 37. Pyrosequencing-based approach for rapid detection of rifampin-resistant Mycobacterium tuberculosis.
    Zhao JR; Bai YJ; Zhang QH; Wang Y; Luo M; Yan XJ
    Diagn Microbiol Infect Dis; 2005 Feb; 51(2):135-7. PubMed ID: 15698720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experimental studies of the antimycobacterial activity of Rifampicine].
    Nitti V; Catena E; Ninni A; Di Filippo A
    Arch Tisiol Mal Appar Respir; 1966 Nov; 21(11):867-910. PubMed ID: 4969274
    [No Abstract]   [Full Text] [Related]  

  • 39. High frequency of mutations in the rpoB gene in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Singapore.
    Lee AS; Lim IH; Tang LL; Wong SY
    J Clin Microbiol; 2005 Apr; 43(4):2026-7. PubMed ID: 15815052
    [No Abstract]   [Full Text] [Related]  

  • 40. [In vitro study on cross resistance of rifampin and rifapentine for Mycobacterium tuberculosis].
    Duanmu HJ; Liu YH; Jiang GL; Wang SM; Fu YH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Mar; 28(3):192-4. PubMed ID: 15854417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.